Three exceptional stocks with enormous potential to buy now

Professional investor Damon Ficklin of Polen Capital highlights three of his favourite high-quality global growth stocks to buy now.

The best way to invest is with a portfolio of the highest-quality growth businesses that can deliver sustainable, above-average earnings growth over the long term. Such exceptional companies not only have the potential to contribute outsized returns, but are also inherently less risky, as their greater earnings stability and financial strength offer a “margin of safety” that typically results in less volatility during turbulent market environments. 

Europe’s software powerhouse

SAP (Frankfurt: SAP) is one of the world’s leading enterprise-software providers and a trusted partner for over two-thirds of Forbes Global 2000 companies. Its systems underpin 77% of the world’s transactions. The pandemic has demonstrated the resilience of the business as customers have seen how valuable SAP’s products are. SAP has a powerful combination of a fast-growing cloud business and a solid core suite of solutions. The stock is attractively valued and given the high switching costs and mission-critical nature of its services we expect SAP to continue to perform strongly.

China’s digital leader

Alibaba (Hong Kong: 9988) is the backbone of e-commerce in China and is very well positioned to continue attracting customers as Chinese consumption grows. The popularity of its core commerce marketplaces – Taobao and Tmall – has allowed Alibaba to establish a dominant position where it benefits from the dual tailwinds of digital-advertising growth and increased e-commerce penetration. Unlike Amazon, Alibaba operates a third-party marketplace model, meaning it does not carry any inventory. That allows the business to expand with limited capital requirements. 

All this has resulted in high operating margins and strong free cash-flow generation, which Alibaba has reinvested into areas that bolster its business, such as payments (through its stake in Ant Financial), a smart-logistics platform, food delivery, offline retail and cloud computing. Some of these newer businesses, such as AliCloud and Cainiao (logistics) are now large enough to start contributing more to overall earnings. 

A secular tailwind for pharmaceuticals

Abbott Laboratories (NYSE: ABT) has a diversified portfolio of stable, high-quality growth businesses. The group’s excellence in innovation has enabled it to lead each segment in which it operates. A key growth driver is the FreeStyle Libre device for diabetes care, which in terms of both revenue and patients is the world’s leading continuous glucose monitor. Libre users are doubling each year. Key elements of its appeal are its ability to eliminate the need for finger-pricking and its pricing strategy. 

Heart health continues to dominate healthcare and Abbott’s innovative cardiovascular device portfolio bodes well. It is led by MitraClip, a minimally invasive treatment for mitral regurgitation (when blood leaks out of one of the heart’s valves). 

Lastly, Abbott’s Alinity diagnostic instruments (which played a leading role in Covid-19 testing) are engineered to be faster and simpler to operate than the division’s previous products. The group also benefits from the secular tailwind of a growing middle-class population in emerging markets, where Abbott makes 40% of its revenues.

Recommended

Imperial Brands has an 8.3% dividend yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% dividend yield – but what’s the catch?

With an impressive dividend yield of 8.3%, Imperial Brands looks to be one of the most attractive income stocks in the FTSE 100 . But investors should…
6 Jul 2022
Can Royal Mail continue to deliver its 7.6% yield?
Share tips

Can Royal Mail continue to deliver its 7.6% yield?

Royal Mail shares are yielding 7.6% this year. But it’s facing some huge challenges, says Rupert Hargreaves. So is Royal Mail’s dividend sustainable?
6 Jul 2022
Saga’s figures are heading in the right direction – so should you buy?
Share tips

Saga’s figures are heading in the right direction – so should you buy?

Saga the over-50s travel and financial services specialist, has been struggling for years. But now, with the pandemic behind, it it is planning for fu…
5 Jul 2022
Is it OK to buy Scottish Mortgage investment trust again?
Investment trusts

Is it OK to buy Scottish Mortgage investment trust again?

Scottish Mortgage investment was hit hard by the tech-stock crash, and it is still being buffeted by headwinds. Should new investors wait for those to…
5 Jul 2022

Most Popular

Ray Dalio’s shrewd $10bn bet on the collapse of European stocks
European stockmarkets

Ray Dalio’s shrewd $10bn bet on the collapse of European stocks

Ray Dalio’s Bridgewater hedge fund is putting its money on a collapse in European stocks. It’s likely to pay off, says Matthew Lynn.
3 Jul 2022
Persimmon yields 12.3%, but can you trust the company to deliver?
Share tips

Persimmon yields 12.3%, but can you trust the company to deliver?

With a dividend yield of 12.3%, Persimmon looks like a highly attractive prospect for income investors. But that sort of yield can also indicate compa…
1 Jul 2022
Is inflation about to drop as recession takes hold?
UK Economy

Is inflation about to drop as recession takes hold?

Central banks are raising interest rates in an attempt to curb soaring inflation. But will that push the economy into recession? John Stepek looks at …
5 Jul 2022